This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Vivus
VVUS : NASDAQ : Health Care
$4.16 | %
Today's Range: 4.04 - 4.45
Avg. Daily Volume: 1,887,400
09/19/14 - 3:59 PM ET

PEER GROUP: Pharmaceuticals



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
VVUS VIVUS INC 4.03 416.94 n/m 130.01 1015.18
HZNP HORIZON PHARMA INC 11.81 883.03 n/m 172.18 429.75
DEPO DEPOMED INC 14.57 853.60 10.87 222.35 91.66
FLML FLAMEL TECHNOLOGIES SA -ADR 14.11 544.38 n/m 29.02 24.06
OMER OMEROS CORP 14.45 491.24 n/m 0.51 -87.96
TTPH TETRAPHASE PHARMACEUTICALS 16.90 438.61 n/m 7.80 21.39
SCLN SCICLONE PHARMACEUTICALS INC 7.18 366.75 17.10 127.04 -4.44
ECYT ENDOCYTE INC 8.58 356.51 31.78 100.31 73.35
SUPN SUPERNUS PHARMACEUTICALS INC 8.28 355.39 n/m 50.35 3029.08
ACRX ACELRX PHARMACEUTICALS INC 7.93 343.98 n/m 28.32 788.36
CEMP CEMPRA INC 10.01 332.76 n/m 8.23 80.05
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

VVUS Ind Avg S&P 500
n/m 41.22 19.69
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs